BioCentury
ARTICLE | Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

August 3, 2015 7:00 AM UTC

Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP), New York, N.Y. Business: Cancer, Neurology, Autoimmune Date completed: 2015-07-29 Type: Private placement of convertible preferred stock Raised: $9...